{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:48:19Z","timestamp":1786736899117,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharm Bioall Sci"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/jpbs.jpbs_368_19","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T08:36:50Z","timestamp":1595234210000},"page":"351","source":"Crossref","is-referenced-by-count":4,"title":["A retrospective study on therapeutic drug monitoring of mood stabilizers in real-life clinical scenario"],"prefix":"10.4103","volume":"12","author":[{"given":"JishaM","family":"Lucca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hawra","family":"Abu-Qurain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah","family":"Almashhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MahdiSaeed","family":"Abumadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0975-7406.290127-1","doi-asserted-by":"crossref","unstructured":"Rybakowski JK Recent advances in the understanding and management of bipolar disorder in adults. F1000Res 2017;6:2033.","DOI":"10.12688\/f1000research.12329.1"},{"key":"key-10.4103\/0975-7406.290127-2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/FTD.0000000000000483","article-title":"Prevalence of therapeutic drug monitoring for lithium and the impact of regulatory warnings: analysis using Japanese claims database","author":"Ooba","year":"2018","journal-title":"Ther Drug Monit"},{"key":"key-10.4103\/0975-7406.290127-3","doi-asserted-by":"crossref","unstructured":"Hiemke C Consensus guideline based therapeutic drug monitoring (TDM) in psychiatry and neurology. Curr Drug Deliv 2016;13:353-61.","DOI":"10.2174\/1567201812666151029100909"},{"key":"key-10.4103\/0975-7406.290127-4","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/FTD.0b013e318296a2ff","article-title":"Therapeutic drug monitoring of psychotropic drugs in China: a nationwide survey","author":"Guo","year":"2013","journal-title":"Ther Drug Monit"},{"key":"key-10.4103\/0975-7406.290127-5","doi-asserted-by":"crossref","unstructured":"Mitchell PB Therapeutic drug monitoring of psychotropic medications. Br J Clin Pharmacol 2001;52:45S-54S.","DOI":"10.1046\/j.1365-2125.2001.00174.x"},{"key":"key-10.4103\/0975-7406.290127-6","unstructured":"Al-Khathami AD, Ogbeide DO Prevalence of mental illness among Saudi adult primary-care patients in central Saudi Arabia. Saudi Med J 2002;23:721-4."},{"key":"key-10.4103\/0975-7406.290127-7","doi-asserted-by":"crossref","unstructured":"Becker SM Detection of somatization and depression in primary care in Saudi Arabia. Soc Psychiatry Psychiatr Epidemiol 2004;39:962-6.","DOI":"10.1007\/s00127-004-0835-4"},{"key":"key-10.4103\/0975-7406.290127-8","doi-asserted-by":"crossref","unstructured":"Thomas SP, Nisha A, Varghese PJ Disability and quality of life of subjects with bipolar affective disorder in remission. Indian J Psychol Med 2016;38:336-40.","DOI":"10.4103\/0253-7176.185941"},{"key":"key-10.4103\/0975-7406.290127-9","doi-asserted-by":"crossref","unstructured":"Bebbington P, Ramana R The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol 1995;30:279-92.","DOI":"10.1007\/BF00805795"},{"key":"key-10.4103\/0975-7406.290127-10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.euroneuro.2005.04.011","article-title":"Prevalence and burden of bipolar disorders in European countries","author":"Pini","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"key-10.4103\/0975-7406.290127-11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative","author":"Merikangas","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"key-10.4103\/0975-7406.290127-12","first-page":"207","article-title":"Psychometric performance of four self-report measures","author":"Leidy","year":"1998","journal-title":"J Affect Disord"},{"key":"key-10.4103\/0975-7406.290127-13","unstructured":"Hirschfeld RMA, Bowden CL, Gitlin MJ, Keck PE, Suppes T, Thase ME, et al. Practice guideline for the treatment of patients with bipolar disorder. Arlington, VA: American Psychiatric Association; 2004. p. 525-612. Available from: https:\/\/psychiatryonline.org\/. [Last accessed on 2019 Nov 6]."}],"container-title":["Journal of Pharmacy And Bioallied Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:47:30Z","timestamp":1786733250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.JPBS_368_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"alternative-id":["290127"],"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_368_19","relation":{},"ISSN":["0975-7406"],"issn-type":[{"value":"0975-7406","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}